Italia markets closed

Aspira Women's Health Inc. (AWH)

NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
0,3742+0,0122 (+3,37%)
Al 12:18PM EST. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente0,3620
Denaro0,3722 x 2900
Lettera0,3750 x 800
Min-Max giorno0,3550 - 0,3750
Intervallo di 52 settimane0,3100 - 2,0800
Media Volume288.998
Beta (5 anni mensile)2,79
Rapporto PE (ttm)N/D
EPS (ttm)-0,3120
Prossima data utili10 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A3,00
  • GlobeNewswire

    Aspira Women’s Health Announces the Commercial Launch of OvaWatch(SM)

    AUSTIN, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, announced the commercial launch of OvaWatchSM, a new non-invasive blood-based test for the assessment of ovarian cancer risk in women with adnexal masses. OvaWatch is part of the Company’s OvaSuiteSM portfolio of commercialized ovarian cancer risk assessment tests, including FDA-cleared assays Ova1® and Overa® (Ova1Plus®). With limi

  • GlobeNewswire

    Aspira Women’s Health Reports Third Quarter 2022 Financial Results

    Increased year-over-year product revenue by 26% to $2.0 million and year-over-year product volume by 29% to 5,524 units Reconfirmed fourth quarter launch of OvaWatch ovarian cancer risk assessment and announced rebranding of the ovarian cancer product portfolio as OvaSuite Executed and fully funded a sponsored research agreement with Harvard’s Dana Farber Cancer Institute, Brigham & Women’s Hospital, and Medical University of Lodz for development of our endometriosis diagnostic testing portfolio

  • GlobeNewswire

    Aspira Women’s Health to Announce Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 10

    AUSTIN, Texas, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the third quarter ended September 30, 2022 before the market open on Thursday, November 10, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:30 am Eastern Time. Details for the call are below: Conference Call &